UK markets closed

Nitto Denko Corporation (NDEKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
68.210.00 (0.00%)
At close: 3:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close68.21
Open68.21
BidN/A x N/A
AskN/A x N/A
Day's range68.21 - 68.21
52-week range68.21 - 95.11
Volume14
Avg. volume73
Market cap10.629B
Beta (5Y monthly)1.17
PE ratio (TTM)14.55
EPS (TTM)4.69
Earnings dateN/A
Forward dividend & yield2.04 (2.99%)
Ex-dividend date30 Mar 2022
1y target estN/A
  • Business Wire

    Nitto Strengthens Oligonucleotide Therapeutic Manufacturing Business

    In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation (Headquarters: Osaka; President: Hideo Takasaki; referred to hereafter as "Nitto") will invest approximately 25 billion Japanese yen in Nitto Denko Avecia Inc. (Headquarters: Massachusetts, USA; referred to hereafter as "Avecia"), a subsidiary of Nitto, and other related business establishments and group companies. This investment will significantly increase the manufacturing capacity of its oligonucleotide therapeutic business.